David Westenberg is senior research analyst and managing director at Piper Sandler covering Tools and Genomics. Prior to joining Piper Sandler in 2021, Westenberg was a senior analyst at Guggenheim Securities, covering diagnostics labs, genomic instruments, and animal health. Prior to joining Guggenheim, he was a senior analyst at CL King, leading the coverage of diagnostics and animal health. Westenberg is a CFA Charter holder, and was a StarMine runner up for stock picking in medical equipment in 2018. He has a Masters in finance from Bocconi University in Milan and a BS in Business Administration from San Francisco State.